Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- University / Academia / Research
- Manufacturing, Other
- Mining
- Aerospace & Air Transport
- Glassware
- Oil, Gas & Refineries
- Water and Wastewater
- Environmental
- Health and Safety
- Air and Climate
- Government
- Food and Beverage
- Energy
- Construction & Construction Materials
Leukemia Suppliers Serving Lithuania
39 companies found
Premium
based inDueren, GERMANY
Since 2005, NIPPON Genetics EUROPE has stood for innovation and quality in biotechnology. In these two decades, we have evolved from a supplier of high quality Japanese technologies to a developer of our own groundbreaking solutions. Our products ...
Enables long term cell storage at -80°C or -196°C. Improved cell recovery and viability after thawing. Ready-to-use freezing media – no programmed or sequential freezing required. Serum-free – no risk of contamination. GMP ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
NOMO-1 established from the bone marrow of a 31-year-old woman with acute myeloid leukemia (AML FAB M5a) at 2nd relapse; described to show strong lysozyme activity in the cytoplasm, phagocytic activities, and cells are responsive to ...
based inSeocho-gu, SOUTH KOREA
Taking the first step in 1945, JW Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and pioneering spirit. We are strengthening our global market competitiveness by developing leading health care ...
Active Ingredients: cyclophosphamide 50mg per 1 ...
based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
K-NK002: A phase 2 clinical study evaluating haplo-identical NK cells to prevent post-transplant relapse in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This study was designed based on promising ...
based inGoettingen, GERMANY
Fassisi GmbH is a manufacturer and developer of on-site rapid test systems, with a focus on the veterinary sector. The quality of our iVD products results from our more than 10 years of experience in the development and production of rapid test ...
The rapid test to detect FeLV antigens in blood of cats. Economical screening test for serum, plasma and wholeblood of cats: Can be used directly without any equipment, Easy on-site usage, All items required are included in the testkit, Storage at ...
based inLund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
Ongoing work to comply with the CE-IVDR (clinical use). The program includes classifier models and supportive gene fusion analysis. Qlucore Diagnostics is a scalable diagnostic solution from data to report, improving clinical? workflow? with ...
based inParis Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
based inMahwah, NEW JERSEY (USA)
KORU is, first and foremost, a patient-centric organization that will go the extra mile for our customers, providers, and partners who depend on our devices. We are a world-class manufacturer of subcutaneous infusion devices that deliver life-saving ...
Primary Immunodeficiency Diseases (PIDD) are a group of over 350 chronic disorders resulting from defects in the body's immune system that are caused by hereditary or genetic defects. PIDD patients have an increased susceptibility to infection due ...
based inRoyston, UNITED KINGDOM
Over 30 years experience manufacturing gas detection instruments and sensors. ION Science has over 30 years of industry experience designing, manufacturing, and supplying PID gas sensors, gas detection instruments, and leak detectors for a wide ...
based inAhmedabad, INDIA
Established in the year 2013 at Ahmedabad (Gujarat, India), we Heet Healthcare Pvt. Ltd. are noteworthy OEM Manufacturer, Exporter, Trader, Importer and Wholesaler of Pharmaceutical products. The offered products are processed using high-grade ...
based inWoodland Hills, CALIFORNIA (USA)
EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...
Mutations in IDH1/2 can lead to the development and/or progression of various types of cancer including secondary glioblastomas and acute myeloid leukemias (AML). IDH1/2 mutations are linked to abnormal histone and DNA methylation ...
based inDaxing District, CHINA
Beijing Challen Biotechnology Co., Ltd. (Challenbio) is a leading Chinese flow cytometer manufacturer, located in Biomedical Base of Daxing District, Beijing. It is a high- technology company specializing in R&D, production and sales of biomedical ...
Our product production process strictly follows relevant standards and undergoes multiple rigorous tests to ensure product quality. We pay great attention to details and use a rigorous attitude to ensure the smooth progress of your experiment or ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-1287 is an investigational oral CDK9 inhibitor that has shown favorable oral bioavailability in preclinical models. TP-1287 is enzymatically cleaved, yielding the active moiety, a potent inhibitor of CDK9.35 Inhibiting CDK9 is thought to ...
based inPanchkula, INDIA
Our organization ISO 9001:2008 certified company, We are leading manufacturers and importers of a wide range of analytical laboratory Instruments. Our product range Single Beam UV-VIS Spectrophotometers , Double Beam UV-VIS Spectrophotometers, ...
Microprocessor Hemoglobin Meter is used to determine the hemoglobin concentration in the blood sample. The measurement hemoglobin concentration is carried out at wavelength of 546 nm. Using state-of-the-art LED technology the green light produced is ...
based inOlivos, ARGENTINA
With a strong development platform and four production sites, AMEGA Biotech develops and produces biosimilars. Exporting recombinant proteins worldwide and focused on central markets registrations, AMEGA Biotech is the leading regional producer.. ...
Interferon alfa is the type that has been found to be most useful in the treatment of certain forms of cancer, including metastatic renal cell carcinoma and hairy cell leukemia. Interferon alfa-2b was also the first molecule to be ...
based inLa Vista, NEBRASKA (USA)
Streck is an ISO-certified biotech company with proven proprietary science and an unwavering commitment to the highest standards in developing and manufacturing Quality Control and diagnostic products in hematology, immunology, molecular ...
CD-Chex CD103 Plus is the only commercially available flow cytometry control that includes CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda. It is a unique, positive procedural control with two distinct abnormal leukocyte populations: CD45+ and ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas like follicular lymphoma (FL) and marginal ...
based inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
XPO1 has been shown to regulate nuclear export of many of the major tumor suppressor proteins and oncogenic cell growth regulators. Overexpression of XPO1 has been reported in many cancer types and is associated with aggressive tumor behavior and ...
based inPearland, TEXAS (USA)
Base Pair Biotechnologies, Inc. is a world-leading provider of highly customized aptamer discovery and development services. The company was founded in 2012. It is privately held and located in the Houston, Texas metropolitan area, close to major ...
Aptamer discovery is a complex process. Customized libraries and selection techniques are employed to achieve selective binding to a target of interest under anticipated conditions. In some cases, selected aptamers may not quite achieve the ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Pursuing an Unmet Need in the Treatment of AML - SENTI-202 is designed to target and eliminate acute myeloid leukemia cells while sparing healthy bone marrow. Our vision is a potential medicine that does not rely on an invasive bone ...